Hangzhou Coco Healthcare Products Co.,Ltd.
Symbool: 301009.SZ
SHZ
9.21
CNYMarktprijs vandaag
89.9693
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
2.50B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 863.1 | 689.5 | 884 | |||||||
balance-sheet.row.short-term-investments | 0 | -20.4 | -21.2 | -23.5 | |||||||
balance-sheet.row.net-receivables | 0 | 213 | 274.5 | 188.2 | |||||||
balance-sheet.row.inventory | 0 | 114.8 | 182.4 | 153.9 | |||||||
balance-sheet.row.other-current-assets | 0 | 13.9 | 12.2 | 27.6 | |||||||
balance-sheet.row.total-current-assets | 0 | 1204.7 | 1158.5 | 1253.8 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 663.4 | 670.4 | 694.8 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.long-term-investments | 0 | 30.1 | 21.5 | 23.7 | |||||||
balance-sheet.row.tax-assets | 0 | 10.1 | 8.2 | 2.1 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | 5.2 | 24.2 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 787.3 | 790.1 | 831.8 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.account-payables | 0 | 439 | 429.9 | 528.5 | |||||||
balance-sheet.row.short-term-debt | 0 | 6.2 | 1.4 | 1.5 | |||||||
balance-sheet.row.tax-payables | 0 | 5.5 | 6.5 | 1.4 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 11.9 | 3.3 | 5.1 | |||||||
Deferred Revenue Non Current | 0 | 45.2 | 39.1 | 6.8 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 0.6 | 0.8 | 0.6 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 57.1 | 42.3 | 11.9 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 11.9 | 3.3 | 5.1 | |||||||
balance-sheet.row.total-liab | 0 | 542.4 | 516.9 | 578.6 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 271.9 | 271.9 | 271.9 | |||||||
balance-sheet.row.retained-earnings | 0 | 300.4 | 284.3 | 348.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 73.2 | 70.8 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 800.4 | 723.2 | 723.2 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 1372.7 | 1352.6 | 1414.7 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.minority-interest | 0 | 76.9 | 79.2 | 92.3 | |||||||
balance-sheet.row.total-equity | 0 | 1449.6 | 1431.8 | 1507 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 9.7 | 0.3 | 0.3 | |||||||
balance-sheet.row.total-debt | 0 | 18.1 | 4.6 | 6.6 | |||||||
balance-sheet.row.net-debt | 0 | -845 | -684.8 | -877.4 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -56.2 | 39.4 | 223.1 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 61.3 | 49.4 | 39.2 | ||||||
cash-flows.row.deferred-income-tax | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.stock-based-compensation | 0 | 6.1 | -3.8 | 3.6 | ||||||
cash-flows.row.change-in-working-capital | 0 | -110.7 | -53.8 | 67.3 | ||||||
cash-flows.row.account-receivables | 0 | -31 | 114.1 | -101.2 | ||||||
cash-flows.row.inventory | 0 | -40.2 | -34 | 4.5 | ||||||
cash-flows.row.account-payables | 0 | -33.5 | -137.7 | 167.6 | ||||||
cash-flows.row.other-working-capital | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.other-non-cash-items | 0 | 68.5 | 15.4 | 66.2 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.acquisitions-net | 0 | 0.6 | 25 | 0.1 | ||||||
cash-flows.row.purchases-of-investments | 0 | -65 | -95 | -150.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 65.2 | 220.1 | 51.1 | ||||||
cash-flows.row.other-investing-activites | 0 | 3.4 | -24.5 | 8.3 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -112.1 | -114.9 | -311.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -149.1 | -80.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | -19 | -0.9 | -23.6 | ||||||
cash-flows.row.other-financing-activites | 0 | -30.8 | 833.8 | 132.7 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -49.9 | 683.8 | 28.5 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 4.2 | -2.6 | -11.6 | ||||||
cash-flows.row.net-change-in-cash | 0 | -195 | 616.8 | 101.2 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 639.5 | 834.4 | 217.6 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 834.4 | 217.6 | 116.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | -37.2 | 50.5 | 395.9 | ||||||
cash-flows.row.capital-expenditure | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.free-cash-flow | 0 | -153.6 | -189.9 | 175.1 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1081.5 | 1186.3 | 1186.4 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 890.6 | 1030.9 | 965.3 | |||||||
income-statement-row.row.gross-profit | 0 | 190.9 | 155.4 | 221.1 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.operating-expenses | 0 | 175.2 | 171.3 | 176.8 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 1065.7 | 1202.2 | 1142.1 | |||||||
income-statement-row.row.interest-income | 0 | 24.2 | 23.3 | 12.6 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.total-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 56.8 | 61.3 | 49.4 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 20.2 | -55.5 | 45.3 | |||||||
income-statement-row.row.income-before-tax | 0 | 19.5 | -56.4 | 43.5 | |||||||
income-statement-row.row.income-tax-expense | 0 | 1.7 | -0.1 | 4.1 | |||||||
income-statement-row.row.net-income | 0 | 20.2 | -43.1 | 39.7 |
Vaak gestelde vragen
Wat is Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) totale activa?
Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) totale activa is 1992017074.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.187.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.026.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.028.
Wat is Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) nettowinst (netto-inkomen)?
De nettowinst is 20184911.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 18052009.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 175169142.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.